GSK at HLTH 2023

We believe the bigger the challenge, the bigger the need for collaboration.

We have long been committed to partnering with the world's best minds and leading institutions and investing in our own capabilities. That's why we’re in Las Vegas at the HLTH conference, 8-11 October 2023.

Our leaders on stage at HLTH

Lisa Banks at HLTH

International healthcare opportunities and innovation

International healthcare opportunities and innovation

Lisa Banks, Vice President, Global Head Digital Health & Innovation

8 October, from 9:55 10:15

Mike Montello at HLTH

Technological triumphs: Groundbreaking technologies reshaping healthcare

Technological triumphs: Groundbreaking technologies reshaping healthcare

Mike Montello, SVP, R&D Digital & Tech, Panel at Fierce Pharma & Life Sciences Forum

8 October – 12:00

Maggie And Kim At HLTH

How digital health can advance health equity

How digital health can advance health equity

From research to patient healthcare access

Kimberly SmithChief Scientific Officer, SVP and Head of R&D of ViiV Healthcare, Maggie CzarnogorskiHead of Digital Innovation and Implementation Science, and Ivor HornHead of Health Equity, Google

9 October, from 12:00 – 12:20

Lisa Banks at HLTH

Let’s make a deal… with pharma

Let’s make a deal… with pharma

Lisa Banks, Vice President, Global Head Digital Health & Innovation

9 October, Sky Stage at 2:102:50

Sara And John At HLTH

Expanding our impact

Expanding our impact

Developments in digital measures and novel data sources that influence how we "get ahead" of disease

John GrahamSenior Vice President Value Evidence and Outcomes, and Sara HughesSVP, Head of Biostatistics and Pipeline Project Management

10 October, from 10:30 – 10:50

Kim At HLTH

Healthcare, policy and advocacy walk into a bar

Healthcare, policy and advocacy walk into a bar

Kimberly Smith, Chief Scientific Officer, SVP and Head of R&D of ViiV Healthcare

10 October, Sky Stage from 11 - 11:40 for the panel discussion

Claudia And Michel At HLTH

Move fast together

Move fast together

How DCT and regulatory strategies collaborate to adopt advanced technology early in development lifecycles

Michel RiderVP Digital Analytics and Performance, Claudia DollinsVP, Head of Precision Medicines, Global Regulatory Affairs

10 October, from 1:30 – 1:50

BIO data wall

#GSKdata wall exhibit

#GSKdata wall exhibit

Make your voice heard by adding your thoughts to our data visualisation wall at Booth 4424.

Visit #GSKdata at Booth 4424

We believe innovation starts when we stop to listen.

So, we created a simple tool for including you in the conversation about health innovation, technology and impacting how we collaborate, co-create and innovate to get ahead of disease together. With the goal of generating more data from HLTH 2023 attendees to further understand what roles technology and innovation will play in healthcare in the future, make your voice heard by adding your thoughts to our data visualisation wall at Booth 4424.

What will we be learning at HLTH?

The conversations amongst the brightest in health and technology have already inspired us. We will be learning from HLTH conference-goers about how digital solutions are bridging teams and breaking traditional biopharma drivers in health innovation. Check in here for daily insights from our data visualisation wall.

  • Pharma

    9%
  • Biotech

    8%
  • Provider

    14%
  • Payer

    6%
  • Tech

    62%
  • Culture

    6%
  • Partners

    9%
  • A novel approach to discovery

    21%
  • Blockbuster medicines and vaccines

    18%
  • Global impact

    19%
  • Using of cutting-edge tech

    26%
  • ...a helpful partner

    36%
  • ...a short cut

    2%
  • ...all hype

    2%
  • ...an accelerator

    59%
  • ...likely to replace me

    1%
  • Fundamental

    26%
  • Worrying

    3%
  • Distracting

    2%
  • Temporary

    1%
  • Revolutionary

    49%
  • Unclear

    20%
  • Being more open to relationships with unexpected partners

    31%
  • Scalability of digital solutions

    26%
  • Deeper patient insight

    27%
  • Better access to leadership teams

    8%
  • Access to proprietary technologies

    9%
  • Yes, my company has clear policies and procedures for using AI tools

    32%
  • No, my company doesn't have sufficient formal guidance on how we can use AI

    16%
  • I'm not sure yet

    44%
  • It's the role of government or other regulators to set

    8%
  • Improving overall societal health to reduce risk of disease

    29%
  • Taking personal measures to limit the spread of disease

    5%
  • Vaccination

    5%
  • Educating individuals to have healthier lifestyles

    26%
  • Developing medical cures

    6%
  • Early intervention

    30%
  • Not be afraid of failure

    23%
  • Embrace agility and speed

    39%
  • Have a growth mindset

    17%
  • Explore new business models

    21%

Careers at GSK

Our goal is to be an outstanding place to work where people can thrive. We bring together the best and brightest minds because we believe everyone has a part to play in shaping the future of our company and the impact we make on the world.

Two women speaking on a couch

Together we are ambitious for patients by:

  • Recruiting and developing outstanding people who believe in our purpose, live our culture, and want to help us achieve our goals
  • Creating a place where people can grow, be their best selves, be safe, and feel welcome, valued, and included
  • Recognising, celebrating, and rewarding success

Search jobs      GSK Careers

BIO Data Wall Rendering

BEHIND THE SCIENCE

Over 1,700 BIO attendees participated in GSK’s real-time survey in June about technology and health innovation across the industry.